2型糖尿病的个性化预防
本综述评估现有行为干预的个性化程度,提出通过更好识别高风险人群、将2型糖尿病分为特定亚组及个体化行为目标来加强个性化。使用更动态实时数据的方法尚处科学初期,虽前景可期但需长期临床结局评估。未来个性化预防需与现有有效干预互补并与社会层面策略协同。
要点
- 临床试验已确立行为干预可使糖尿病前期进展为2型糖尿病的风险减半。
- 现有干预已部分个性化,但需更好识别高风险人群、细分亚组并个体化行为目标。
- 动态实时数据方法尚处初期,需长期临床结局评估,且应与现有干预及社会策略协同。
核心结论
- 未来2型糖尿病个性化预防方法需与正在推广且已证明有效的个体层面干预互补,并与社会层面策略协同,至少不应分散对社会层面策略的注意力。
研究设计与样本
- 综述,评估现有干预的个性化程度并概述通过更好识别高风险人群、将2型糖尿病分为特定亚组及个体化行为目标来实现更大个性化的途径。
主要发现
- 临床试验已确立行为干预可使糖尿病前期进展为2型糖尿病的风险减半。
- 将行为干预的效力证据转化为大规模有效的现实世界干预仍是持续挑战。
- 使用更动态实时数据的方法尚处科学初期,虽有前景但需针对临床结局进行长期评估。
关键数值与推荐
- 行为干预可使糖尿病前期进展为2型糖尿病的风险减半。
临床怎么用
- 原文未据此给出推荐。
局限性
- 使用更动态实时数据的方法尚处科学初期,虽有前景但需针对临床结局进行长期评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It is well established from clinical trials that behavioural interventions can halve the risk of progression from prediabetes to type 2 diabetes but translating this evidence of efficacy into effective real-world interventions at scale is an ongoing challenge. A common suggestion is that future preventive interventions need to be more personalised in order to enhance effectiveness. This review evaluates the degree to which existing interventions are already personalised and outlines how greater personalisation could be achieved through better identification of those at high risk, division of type 2 diabetes into specific subgroups and, above all, more individualisation of the behavioural targets for preventive action. Approaches using more dynamic real-time data are in their scientific infancy. Although these approaches are promising they need longer-term evaluation against clinical outcomes. Whatever personalised preventive approaches for type 2 diabetes are developed in the future, they will need to be complementary to existing individual-level interventions that are being rolled out and that are demonstrably effective. They will also need to ideally synergise with, and at the very least not detract attention from, efforts to develop and implement strategies that impact on type 2 diabetes risk at the societal level.
引用
- Wareham NJ. Personalised prevention of type 2 diabetes. Diabetologia. 2022. PMID: 35916901. doi:10.1007/s00125-022-05774-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。